407 related articles for article (PubMed ID: 18493620)
1. Pharmacological inhibition of nicotinamide phosphoribosyltransferase/visfatin enzymatic activity identifies a new inflammatory pathway linked to NAD.
Busso N; Karababa M; Nobile M; Rolaz A; Van Gool F; Galli M; Leo O; So A; De Smedt T
PLoS One; 2008 May; 3(5):e2267. PubMed ID: 18493620
[TBL] [Abstract][Full Text] [Related]
2. Nicotinamide phosphoribosyltransferase as a target in inflammation- related disorders.
Montecucco F; Cea M; Cagnetta A; Damonte P; Nahimana A; Ballestrero A; Del Rio A; Bruzzone S; Nencioni A
Curr Top Med Chem; 2013; 13(23):2930-8. PubMed ID: 24171767
[TBL] [Abstract][Full Text] [Related]
3. Nicotinamide phosphoribosyltransferase (NAMPT) inhibitors as therapeutics: rationales, controversies, clinical experience.
Montecucco F; Cea M; Bauer I; Soncini D; Caffa I; Lasigliè D; Nahimana A; Uccelli A; Bruzzone S; Nencioni A
Curr Drug Targets; 2013 Jun; 14(6):637-43. PubMed ID: 23531116
[TBL] [Abstract][Full Text] [Related]
4. Nicotinamide phosphoribosyltransferase (Nampt) in carcinogenesis: new clinical opportunities.
Chen H; Wang S; Zhang H; Nice EC; Huang C
Expert Rev Anticancer Ther; 2016 Aug; 16(8):827-38. PubMed ID: 27186719
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of nicotinamide phosphoribosyltransferase (NAMPT) in cancer: a patent review.
Gasparrini M; Giovannuzzi S; Nocentini A; Raffaelli N; Supuran CT
Expert Opin Ther Pat; 2024 Jul; 34(7):565-582. PubMed ID: 38861278
[TBL] [Abstract][Full Text] [Related]
6. Novel Mechanism for Nicotinamide Phosphoribosyltransferase Inhibition of TNF-α-mediated Apoptosis in Human Lung Endothelial Cells.
Oita RC; Camp SM; Ma W; Ceco E; Harbeck M; Singleton P; Messana J; Sun X; Wang T; Garcia JGN
Am J Respir Cell Mol Biol; 2018 Jul; 59(1):36-44. PubMed ID: 29337590
[TBL] [Abstract][Full Text] [Related]
7. Intracellular NAMPT-NAD+-SIRT1 cascade improves post-ischaemic vascular repair by modulating Notch signalling in endothelial progenitors.
Wang P; Du H; Zhou CC; Song J; Liu X; Cao X; Mehta JL; Shi Y; Su DF; Miao CY
Cardiovasc Res; 2014 Dec; 104(3):477-88. PubMed ID: 25341895
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of Nicotinamide Phosphoribosyltransferase (NAMPT), an Enzyme Essential for NAD+ Biosynthesis, Leads to Altered Carbohydrate Metabolism in Cancer Cells.
Tan B; Dong S; Shepard RL; Kays L; Roth KD; Geeganage S; Kuo MS; Zhao G
J Biol Chem; 2015 Jun; 290(25):15812-15824. PubMed ID: 25944913
[TBL] [Abstract][Full Text] [Related]
9. Nicotinamide phosphoribosyltransferase/visfatin expression by inflammatory monocytes mediates arthritis pathogenesis.
Présumey J; Courties G; Louis-Plence P; Escriou V; Scherman D; Pers YM; Yssel H; Pène J; Kyburz D; Gay S; Jorgensen C; Apparailly F
Ann Rheum Dis; 2013 Oct; 72(10):1717-24. PubMed ID: 23313810
[TBL] [Abstract][Full Text] [Related]
10. Proinflammatory actions of visfatin/nicotinamide phosphoribosyltransferase (Nampt) involve regulation of insulin signaling pathway and Nampt enzymatic activity.
Jacques C; Holzenberger M; Mladenovic Z; Salvat C; Pecchi E; Berenbaum F; Gosset M
J Biol Chem; 2012 Apr; 287(18):15100-8. PubMed ID: 22399297
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of nicotinamide phosphoribosyltransferase (NAMPT), the rate-limiting enzyme of the nicotinamide adenine dinucleotide (NAD) salvage pathway, to target glioma heterogeneity through mitochondrial oxidative stress.
Sharma P; Xu J; Williams K; Easley M; Elder JB; Lonser R; Lang FF; Lapalombella R; Sampath D; Puduvalli VK
Neuro Oncol; 2022 Feb; 24(2):229-244. PubMed ID: 34260721
[TBL] [Abstract][Full Text] [Related]
12. NAMPT in regulated NAD biosynthesis and its pivotal role in human metabolism.
Burgos ES
Curr Med Chem; 2011; 18(13):1947-61. PubMed ID: 21517777
[TBL] [Abstract][Full Text] [Related]
13. Pharmacological inhibition of nicotinamide phosphoribosyltransferase (NAMPT), an enzyme essential for NAD+ biosynthesis, in human cancer cells: metabolic basis and potential clinical implications.
Tan B; Young DA; Lu ZH; Wang T; Meier TI; Shepard RL; Roth K; Zhai Y; Huss K; Kuo MS; Gillig J; Parthasarathy S; Burkholder TP; Smith MC; Geeganage S; Zhao G
J Biol Chem; 2013 Feb; 288(5):3500-11. PubMed ID: 23239881
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of nicotinamide phosphoribosyltransferase modifies LPS-induced inflammatory responses of human monocytes.
Schilling E; Wehrhahn J; Klein C; Raulien N; Ceglarek U; Hauschildt S
Innate Immun; 2012 Jun; 18(3):518-30. PubMed ID: 21975728
[TBL] [Abstract][Full Text] [Related]
15. Nampt and its potential role in inflammation and type 2 diabetes.
Garten A; Petzold S; Schuster S; Körner A; Kratzsch J; Kiess W
Handb Exp Pharmacol; 2011; (203):147-64. PubMed ID: 21484571
[TBL] [Abstract][Full Text] [Related]
16. [Research advances on the roles of nicotinamide phosphoribosyltransferase in inflammation].
Huang J; Wei EQ; Lu YB
Zhejiang Da Xue Xue Bao Yi Xue Ban; 2014 Mar; 43(2):234-9. PubMed ID: 24782383
[TBL] [Abstract][Full Text] [Related]
17. NAD metabolism fuels human and mouse intestinal inflammation.
Gerner RR; Klepsch V; Macheiner S; Arnhard K; Adolph TE; Grander C; Wieser V; Pfister A; Moser P; Hermann-Kleiter N; Baier G; Oberacher H; Tilg H; Moschen AR
Gut; 2018 Oct; 67(10):1813-1823. PubMed ID: 28877980
[TBL] [Abstract][Full Text] [Related]
18. Targeting the NAD
Ye C; Qi L; Li X; Wang J; Yu J; Zhou B; Guo C; Chen J; Zheng S
Cell Commun Signal; 2020 Jan; 18(1):16. PubMed ID: 32005247
[TBL] [Abstract][Full Text] [Related]
19. Pre-B cell colony enhancing factor/NAMPT/visfatin in inflammation and obesity-related disorders.
Moschen AR; Gerner RR; Tilg H
Curr Pharm Des; 2010 Jun; 16(17):1913-20. PubMed ID: 20370672
[TBL] [Abstract][Full Text] [Related]
20. Channeling Nicotinamide Phosphoribosyltransferase (NAMPT) to Address Life and Death.
Velma GR; Krider IS; Alves ETM; Courey JM; Laham MS; Thatcher GRJ
J Med Chem; 2024 Apr; 67(8):5999-6026. PubMed ID: 38580317
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
